Literature DB >> 22593033

Accounting for biases when linking empirical studies and simulation models.

Jeremy D Goldhaber-Fiebert1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22593033      PMCID： PMC3979337          DOI： 10.1177/0272989X12441398

Source DB:  PubMed          Journal:  Med Decis Making        ISSN： 0272-989X            Impact factor:   2.583


× No keyword cloud information.
  10 in total

Review 1.  Bayesian methods in meta-analysis and evidence synthesis.

Authors:  A J Sutton; K R Abrams
Journal:  Stat Methods Med Res       Date:  2001-08       Impact factor: 3.021

2.  Policy implications of adjusting randomized trial data for economic evaluations: a demonstration from the ASCUS-LSIL Triage Study.

Authors:  Nicole G Campos; Philip E Castle; Mark Schiffman; Jane J Kim
Journal:  Med Decis Making       Date:  2011-12-06       Impact factor: 2.583

3.  Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

Authors:  Milton C Weinstein; Bernie O'Brien; John Hornberger; Joseph Jackson; Magnus Johannesson; Chris McCabe; Bryan R Luce
Journal:  Value Health       Date:  2003 Jan-Feb       Impact factor: 5.725

4.  The confidence profile method: a Bayesian method for assessing health technologies.

Authors:  D M Eddy
Journal:  Oper Res       Date:  1989 Mar-Apr       Impact factor: 3.310

Review 5.  Review of guidelines for good practice in decision-analytic modelling in health technology assessment.

Authors:  Z Philips; L Ginnelly; M Sculpher; K Claxton; S Golder; R Riemsma; N Woolacoot; J Glanville
Journal:  Health Technol Assess       Date:  2004-09       Impact factor: 4.014

Review 6.  Empirically evaluating decision-analytic models.

Authors:  Jeremy D Goldhaber-Fiebert; Natasha K Stout; Sue J Goldie
Journal:  Value Health       Date:  2010-03-10       Impact factor: 5.725

7.  30 years of pharmaceutical cost-utility analyses: growth, diversity and methodological improvement.

Authors:  Peter J Neumann; Chi-Hui Fang; Joshua T Cohen
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

8.  Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7.

Authors:  David M Eddy; William Hollingworth; J Jaime Caro; Joel Tsevat; Kathryn M McDonald; John B Wong
Journal:  Value Health       Date:  2012 Sep-Oct       Impact factor: 5.725

9.  Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.

Authors:  Mark C Simmonds; Julian P T Higgins; Lesley A Stewart; Jayne F Tierney; Mike J Clarke; Simon G Thompson
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

Review 10.  Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment.

Authors:  Goodarz Danaei; Carlene M M Lawes; Stephen Vander Hoorn; Christopher J L Murray; Majid Ezzati
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321
  10 in total
  1 in total

Review 1.  Concordance between decision analysis and matching systematic review of randomized controlled trials in assessment of treatment comparisons: a systematic review.

Authors:  Rahul S Mhaskar; Hesborn Wao; Helen Mahony; Ambuj Kumar; Benjamin Djulbegovic
Journal:  BMC Med Inform Decis Mak       Date:  2014-07-15       Impact factor: 2.796
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.